Statistics
Publications
2
Citations
133
H-Index
2
Active since
2017
Affiliations
Jason Bermak is an author at Janssen Scientific Affairs (United States) specializing in atypical antipsychotic treatment, long-acting injectable antipsychotics, and pharmacy.
Publications per year
2017–2017
2
2
Does Half-Life Matter After Antipsychotic Discontinuation?
Peter J. Weiden, Edward Kim, Jason Bermak et al. · The Journal of Clinical Psychiatry · 2017 · 90 citations · Full text
H. Lynn Starr, Jason Bermak, Lian Mao et al. · Schizophrenia Research · 2017 · 43 citations · Full text
1–2 of 2